Maliszewski, Charles R.
Amgen Incorporated,
United States
2025 Rank: 126138
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Developmental Biology
Rank in SubField 1: 3285 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 126138 | 141990 |
| Total Cites | 16313 | 17418 |
| H-index | 60 | 62 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 821 | 846 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 4636 | 4895 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13256 | 13890 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.25 |
| Self-Citation Percentage |
6.34%
|
|
Maliszewski, Charles R.
Amgen Incorporated,
United States
2024 Rank: 116502
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Developmental Biology
Rank in SubField 1: 3101 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 116502 | 132438 |
| Total Cites | 16004 | 17101 |
| H-index | 60 | 61 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 809 | 833 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 4571 | 4829 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12982 | 13610 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.26 |
| Self-Citation Percentage |
6.41%
|
|
Maliszewski, Charles R.
Amgen Incorporated,
United States
2023 Rank: 106759
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Developmental Biology
Rank in SubField 1: 2925 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 106759 | 123308 |
| Total Cites | 15755 | 16851 |
| H-index | 60 | 61 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 803 | 827 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 4512 | 4771 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12749 | 13377 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.26 |
| Self-Citation Percentage |
6.50%
|
|
Maliszewski, Charles R.
Amgen Incorporated,
United States
2022 Rank: 98102
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Developmental Biology
Rank in SubField 1: 2757 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 98102 | 113731 |
| Total Cites | 15346 | 16436 |
| H-index | 60 | 61 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 791 | 814 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 4408 | 4662 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12385 | 13009 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.26 |
| Self-Citation Percentage |
6.63%
|
|
Maliszewski, Charles R.
Amgen Incorporated,
United States
2021 Rank: 93971
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2643 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 93971 | 107590 |
| Total Cites | 15075 | 16152 |
| H-index | 59 | 61 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 778 | 801 |
| Number of Single+First+Last Authored Papers | 47 | 47 |
| Total Cites to Single+First+Last Authored Papers | 4334 | 4587 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12166 | 12781 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.26 |
| Self-Citation Percentage |
6.67%
|
|
Maliszewski, Charles R.
Amgen Incorporated,
United States
2020 Rank: 83557
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2368 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 83557 | 96170 |
| Total Cites | 14641 | 15706 |
| H-index | 59 | 61 |
| Hm-index | 14 | 14 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 762 | 782 |
| Number of Single+First+Last Authored Papers | 47 | 47 |
| Total Cites to Single+First+Last Authored Papers | 4239 | 4487 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11784 | 12389 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.27 |
| Self-Citation Percentage |
6.78%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.